RMD

ResMed Inc.

$234.11

-0.69%
SectorHealthcareIndustryMedical Instruments & SuppliesCountryUnited States

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution.

Source: Yahoo Finance
AI summary

Price & performance

1M+6.4%
3M+10.7%
YTD-4.1%
1Y-4.6%
52-week range—
Beta0.68
Full chart and returns against a benchmark

Q-Score

80/ 100

Quality against peers; 50 is the peer median.

Growth58
Risk78
Performance62
Valuation59
Profitability86
Leverage67
Sentiment45
Every score and metric

News sentiment

Open News

Latest results · FY 2026

Revenue$5.7B+9.9%
Net income$1.5B+8.8%
Net margin26.9%-0.3 pts
Historical fundamentals

Red flags in filings

1active red flag
Auditor changeAug 17, 2026
Filings, findings and the timeline

Revenue exposure

37%of revenue from outside the US
United States63%
Non Us37%
Regions, segments, customers and suppliers

Valuation

RMDIndustryP/E20.6749.36P/S5.743.73EV/EBITDA15.4823.12P/B5.543.92PEG1.911.91
Dividend yield1.08%
Every valuation metric

Earnings

Jan 28next report, after the close
EPS estimate$2.67
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate